A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Author： Muderspach L.I. Blessing J.A. Levenback C. Moore J.L.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.81, Iss.2, 2001-05, pp. : 213-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topotecan in Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

By Bookman M.A. Blessing J.A. Hanjani P. Herzog T.J. Andersen W.A.

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 446-449

Elsevier

Access to resources Recommend Favorite

Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

By Schilder R.J. Blessing J.A. Morgan M. Mangan C.E. Rader J.S.

Gynecologic Oncology, Vol. 76, Iss. 2, 2000-02 ,pp. : 204-207

Elsevier

Access to resources Recommend Favorite

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study

By Fracasso P.M. Blessing J.A. Wolf J. Rocereto T.F. Berek J.S. Waggoner S.

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite

Phase II Evaluation of Altretamine for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Arseneau J.

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 100-102

Academic Press

Access to resources Recommend Favorite

A Phase II Trial of CPT-11 in Recurrent Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Look K.Y. Blessing J.A. Levenback C. Kohler M. Chafe W. Roman L.D.

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 334-338

Elsevier

Access to resources Recommend Favorite